Amniotic Membrane Market: Information by Type (Cryopreserved and Lyophilized), Application (Surgical Wounds, Ophthalmology, Stem Cell Biology, Regenerative Medicine, Others), by End User (Hospitals & Clinics, Others) and Region - Global Forecast till 2027
Market Highlights
The Global Amniotic Membrane Market is estimated to be valued at USD 2,690.22 Million by 2025 and is expected to register a CAGR of 12.67% during the forecast period.
The cryopreservation amniotic membrane segment is expected to lead the market and register a substantial CAGR to reach USD 1,339.66 Million by the end of 2025. The rising number of ocular surgeries is expected to drive the market growth. However, the lyophilized amniotic membrane segment is projected to exhibit the highest CAGR of 14.69% from 2019 to 2025. The rising number of surgeries, increasing number of reconstruction procedures and cosmetic surgeries, and venous and pressure leg ulcers is driving the growth of the segment.
The Americas accounted for the largest market share of 37.4% in 2018, and the regional market is projected to register a CAGR of 11.75% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The India market is projected to exhibit the highest growth rate of 14.09% during the forecast period of 2019 to 2025.
Segment Analysis
The global amniotic membrane market has been segmented on the basis of type, applications, end user and region. On the basis of type, the market has been divided into the cryopreserved amniotic membrane and lyophilized amniotic membrane. The cryopreserved amniotic membrane segment held the majority market share in 2018. However, lyophilized amniotic membrane is expected to be the fastest growing owing to the rising number of surgeries and an increasing number of reconstruction procedures & cosmetic surgeries.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5645
Regional Analysis
Geographically, the global amniotic membrane market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, the Americas was the largest market for the amniotic membrane in 2018 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The increasing prevalence of cicatricial pemphigoid and Stevens-Johnson syndrome; pterygium; persistent epithelial defects with ulceration; conjunctival surface reconstruction; and ocular surface reconstruction in patients with chemical and thermal burns in Europe are driving the growth of the amniotic membrane market in the region. Germany accounted for the largest market share of 25.3% in 2018, and the country-level market is projected to register a CAGR of 11.36% during the forecast period.
Key Industry Participants
Market Research Future (MRFR) recognizes Applied Biologics (US), Alliqua BioMedical, Inc. (US), Integra LifeSciences (US), Skye Biologics Inc. (California), MiMedx (US), Amniox Medical, Inc. (Florida), Katena Products, Inc. (US), Human Regenerative Technologies, LLC (US), Amnio Technology, LLC (US), and Osiris Therapeutics, Inc. (US) as the key players in the global amniotic membrane market.
Key Findings of the Study:
- The Global Amniotic Membrane Market is projected to reach over USD 2,690.22 million by 2025 at 67% CAGR during the review period of 2019 to 2025
- Americas accounted for the largest market share with North America being the major contributor to the growth of the market.
- The lyophilized amniotic membrane segment is projected to register the highest CAGR of 14.69% during the forecast period owing to the rising number of ocular surgeries.
- Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies. Moreover, they are focusing on e-commerce for distribution.
Table of Content
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 Definition 15
2.2 Scope Of The Study 15
2.3 Assumptions & Limitations 15
2.3.1 Assumptions 15
2.3.2 Limitations 15
2.4 Market Structure 16
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
4.1 Introduction 26
4.2 Drivers 27
4.2.1 Rising Amniotic Membrane Transplantations 27
4.2.2 Rapid Growth In The Geriatric Population 27
4.2.3 Increasing Research Activities 28
4.3 Restraints 28
4.3.1 Rising Healthcare Cost 28
4.3.2 Stringent Regulatory Policies 28
4.4 Opportunities 29
4.4.1 Entering Developing Economies 29
4.4.2 Increasing Awareness About The Advantages Of Amniotic Membrane Transplant 29
5 MARKET FACTOR ANALYSIS
5.1 Value Chain Analysis 30
5.1.1 R&D 30
5.1.2 Manufacturing 30
5.1.3 Distribution & Sales 30
5.1.4 Post-Sales Monitoring 31
5.2 Porter’s Five Forces Analysis 31
5.2.1 Bargaining Power Of Suppliers 31
5.2.2 Bargaining Power Of Buyers 32
5.2.3 Threat Of New Entrants 32
5.2.4 Threat Of Substitutes 32
5.2.5 Intense Rivalry 32
5.3 Investment Opportunities 33
5.4 Pricing Analysis 33
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/amniotic-membrane-market-5645
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Related Report:
- Spinal Traction Market Research Report- Global Forecast till 2023
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Amniotic Membrane Market: Information by Type (Cryopreserved and Lyophilized), Application (Surgical Wounds, Ophthalmology, Stem Cell Biology, Regenerative Medicine, Others), by End User (Hospitals & Clinics, Others) and Region - Global Forecast till 2027Market HighlightsThe Global Amniotic Membrane Market is estimated to be valued at USD 2,690.22 Million by 2025 and is expected to register a CAGR of 12.67% during the forecast period.The cryopreservation amniotic membrane segment is expected to lead the market and register a substantial CAGR to reach USD 1,339.66 Million by the end of 2025.
However, the lyophilized amniotic membrane segment is projected to exhibit the highest CAGR of 14.69% from 2019 to 2025.
The rising number of surgeries, increasing number of reconstruction procedures and cosmetic surgeries, and venous and pressure leg ulcers is driving the growth of the segment.The Americas accounted for the largest market share of 37.4% in 2018, and the regional market is projected to register a CAGR of 11.75% during the forecast period.
Segment AnalysisThe global amniotic membrane market has been segmented on the basis of type, applications, end user and region.
The cryopreserved amniotic membrane segment held the majority market share in 2018.
However, lyophilized amniotic membrane is expected to be the fastest growing owing to the rising number of surgeries and an increasing number of reconstruction procedures & cosmetic surgeries.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5645Regional AnalysisGeographically, the global amniotic membrane market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa.
The new Amniotic Products Market report offers a comprehensive study of the current scenario of the market including major market dynamics.
Also, it highlights the in-depth marketing research with the newest trends, drivers, and segments with reference to regional and country.
Further, this report profiles top key players and analyze their market share, strategic development, and other development across the world.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the amniotic products market include MiMedx (US), Smith & Nephew (UK), Organogenesis Inc. (US), Integra LifeSciences (US), Stryker (US), Applied Biologics (US), Celularity, Inc. (US), Katena Products, Inc. (US), Lucina BioSciences (US), Next Biosciences (South Africa), Skye Biologics Holdings, LLC (US), Surgenex (US), TissueTech, Inc. (US), Ventris Medical, LLC (US), StimLabs LLC (US), VIVEX Biologics, Inc. (US), LifeCell International Pvt.
Ltd. (India), NuVision Biotherapies Ltd. (UK), Genesis Biologics (US), Surgilogix (US), Tides Medical (US), Orthofix Medical Inc. (US), AlloSource (US), Merakris Therapeutics (US), and MTF Biologics (US).
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Amniotic Products Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/amniotic-products-market/download-sampleMarket DynamicsThe growing demand for amniotic-derived products among the target patient population is expected to drive market growth.
